Skip to content
Screener

Neurocrine Biosciences NBIX Q1 2026 earnings

Reported May 5, 2026 · After market close

Revenue$814.5MBeat by $46.2M
EPS$1.94Beat by $0.66
Revenue estimate$768.3M
EPS estimate$1.28

Next report

Oct 27, 2026 (in a month)
Revenue estimate$1.0B
EPS estimate$2.59

Financials

Q1 2026

Income statement

See full
Revenue$814.5M+42.2%
Gross profit$800.7M+42.1%
Operating income$193.4M+719%
Net income$197.9M+2,405%
EPS (diluted)$1.91+2,287%

Balance sheet

See full
Cash & equivalents$274.5M+35.8%
Total debt$463.5M-6.0%
Total equity$3.4B+34.4%
Total assets$4.9B+33.0%

Cash flow

See full
Operating cash flow$145.8M+125%
CapEx$9.1M-15.0%
Free cash flow$136.7M+153%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$13.22B+19.9%
Enterprise value$13.41B+18.5%
P/E19.8×-16.3×
P/S4.3×-0.3×

Profitability

See full
Gross margin98.2%-0.3pp
Operating margin25.4%+4.9pp
Net margin21.6%+8.9pp
FCF margin26.8%+6.4pp

Returns & leverage

See full
Return on equity22.5%+10.1pp
Debt / equity0.1×-0.1×
Current ratio2.9×-0.2×

Segments

By segment

See full
Reportable Segment$814.5M+42.2%

By product

See full
Collaboration revenues$3.5M-60.7%

FAQ

When did Neurocrine Biosciences report Q1 2026 earnings?
Neurocrine Biosciences (NBIX) reported Q1 2026 earnings on May 5, 2026 after market close.
What were Neurocrine Biosciences's Q1 2026 revenue and EPS?
Neurocrine Biosciences reported revenue of $814.5M and eps of $1.94 for Q1 2026.
Did Neurocrine Biosciences beat estimates in Q1 2026?
Revenue beat the consensus estimate of $768.3M by $46.2M. EPS beat the consensus estimate of $1.28 by $0.66.
How did Neurocrine Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 42.2% from $572.6M a year earlier and eps grew 2325.0% from $0.08.
Where can I find Neurocrine Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000914475-26-000025) and the 10-Q periodic report (0000914475-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.